Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | BRD2 | P25440 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL933909 | 0.81 | TSHR (0.35) | TSHRBRD4BRD2LMNAKMT2A | |
| SCHEMBL28324682 | 0.80 | TSHR (0.34) | TSHRLMNAKMT2ABLM | |
| SCHEMBL8218264 | 0.80 | ALDH1A1 (0.37) | TSHRLMNAKMT2APIK3CDMAPT | |
| SCHEMBL28026140 | 0.79 | BRD4 (0.30) | BRD4BRD2 | |
| SCHEMBL1067025 | 0.77 | BRD4 (0.33) | TSHRBRD4BRD2LMNAKMT2A | |
| SCHEMBL5068820 | 0.77 | BRD4 (0.33) | TSHRBRD4BRD2LMNAKMT2A | |
| SCHEMBL29127 | 0.77 | BRD4 (0.33) | TSHRBRD4BRD2LMNAKMT2A | |
| SCHEMBL1068142 | 0.77 | BRD4 (0.33) | TSHRBRD4BRD2LMNAKMT2A | |
| SCHEMBL11318608 | 0.77 | BRD4 (0.33) | TSHRBRD4BRD2LMNAKMT2A | |
| SCHEMBL6881621 | 0.76 | TSHR (0.32) | TSHRLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199933-A1 | A FIBRE BINDER COMPOSITION FOR RETAINING FIBRES AND OTHER PARTICLES ON A BUILDING SITE | ADMANSTARS B.V (NL) | 2024-06-20 | — | — | US | claimed |
| EP-4323453-A1 | A FIBRE BINDER COMPOSITION FOR RETAINING FIBRES AND OTHER PARTICLES ON A BUILDING SITE | Fiberbinder ApS (DK) | 2024-02-21 | — | — | EP | claimed |
| US-20230398108-A1 | Pharmaceutical Compositions of a Kinase Inhibitor | EXELIXIS, INC. | 2023-12-14 | — | — | US | claimed |
| EP-4240333-A1 | PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR | Exelixis, Inc. (US) | 2023-09-13 | — | — | EP | claimed |
| US-11666514-B2 | Fibrous structures containing polymer matrix particles with perfume ingredients | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-06 | — | — | US | claimed |
| CN-115710559-A | Methods and compositions for improving corn yield | 新叶共生有限公司 | 2023-02-24 | — | — | CN | claimed |
| EP-4017563-A1 | NITRIC OXIDE GENERATING SYSTEMS | Nota Laboratories, LLC (US) | 2022-06-29 | — | — | EP | claimed |
| US-20220176062-A1 | NITRIC OXIDE GENERATING SYSTEMS | NOTA Laboratories, LLC | 2022-06-09 | — | — | US | claimed |
| WO-2022098828-A1 | PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR | EXELIXIS, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| US-10953129-B2 | Wetness indicator compositions comprising leuco dyes | Savarè I.C. S.r.l. (IT) | 2021-03-23 | — | — | US | claimed |
| EP-2158091-A2 | COATING COMPOSITION | Hewlett-Packard Development Company, L.P. (US) | 2010-03-03 | — | — | EP | claimed |
| US-20080317797-A1 | TOOTH WHITENING PRODUCTS AND METHODS OF MAKING THE SAME | LORNAMEAD BRANDS, INC. (US) | 2008-12-25 | — | — | US | claimed |
| WO-2008157261-A2 | COATING COMPOSITION | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2008-12-24 | — | — | WO | claimed |
| WO-2008036051-A1 | FIBER STRUCTURES AND PROCESS FOR THEIR PREPARATION | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2008-03-27 | — | — | WO | claimed |
| US-7112265-B1 | Disposable test strips with integrated reagent/blood separation layer | LIFESCAN SCOTLAND LIMITED (GB) | 2006-09-26 | — | — | US | claimed |
| WO-2005123024-A1 | TOOTH WHITENING PRODUCTS AND METHODS OF MAKING THE SAME | LORNAMEAD BRANDS, INC. (US) | 2005-12-29 | — | — | WO | claimed |
| US-20050276760-A1 | Tooth for whitening products and methods of making the same | LORNAMEAD BRANDS, INC. (US) | 2005-12-15 | — | — | US | claimed |
| US-20020100725-A1 | Method for preparing thin fiber-structured polymer web | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2002-08-01 | — | — | US | claimed |
| US-5095054-A | Molding premixes of a melt of a degraded starch and hydrophobic water-insoluble thermoplastic polymer; dimensional stability; toughness; humidity resistance; receptivity | WARNER-LAMBERT COMPANY (US) | 1992-03-10 | — | — | US | claimed |
| EP-0407350-A2 | Polymer base blend compositions containing destructurized starch | WARNER-LAMBERT COMPANY (US) | 1991-01-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398108-A1 | Pharmaceutical Compositions of a Kinase Inhibitor | MET, MINK1, PEAK1 | TSHR 3623/4885BRD4 2513/4885BRD2 2458/4885 |
| US-11666514-B2 | Fibrous structures containing polymer matrix particles with perfume ingredients | FSCN1, FLNA, PFN1 | TSHR 4800/4885BRD4 3553/4885BRD2 3874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.